Skip to main content
Premium Trial:

Request an Annual Quote

University Hospitals Leuven Joins Validation Effort for Agendia MammaPrint, BluePrint IVD Kit

NEW YORK (GenomeWeb) – Agendia said today that Belgium's University Hospitals Leuven has agreed to participate in a co-validation effort for an in vitro diagnostic kit version of the company's MammaPrint and BluePrint breast cancer assays.

Agendia said this June that it was extending its relationship with Agilent Technologies to develop an RNA sequencing-based version of its existing MammaPrint and BluePrint tests, which will allow cancer centers and other customers to run these tests on existing next-generation sequencing instruments in their own laboratories, rather than sending them to Agendia for centralized processing.

UZ Leuven will join the Institut Curie, whose participation Agendia announced earlier this week, in helping to validate the new NGS kits. Like Institut Curie, UZ Leuven will process breast tumor samples from patients enrolled in the study using the NGS-based MammaPrint BluePrint Kit. Agendia will then compare these results with those from the existing microarray-based MammaPrint test, performed at the company’s Amsterdam CLIA-certified and CAP-accredited laboratory.

Marjolaine Baldo, commercial vice president for Europe, the Middle East, and Africa at Agendia, said in a statement that the co-validation is "one of the final steps to complete before we launch our CE-marked MammaPrint BluePrint Kit in 2018."


The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.